{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:34:28Z","timestamp":1790048068909,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bcp.2020.114315","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T19:54:17Z","timestamp":1604346857000},"page":"114315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI"],"prefix":"10.1016","volume":"183","author":[{"given":"Guanxing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017diga","family":"Jakopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongren","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10204","key":"10.1016\/j.bcp.2020.114315_b0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bcp.2020.114315_b0010","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"E. American heart association council on, C. Prevention Statistics, S. Stroke Statistics, Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"517","key":"10.1016\/j.bcp.2020.114315_b0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0481","article-title":"Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis","volume":"11","author":"Barrett","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"24","key":"10.1016\/j.bcp.2020.114315_b0020","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.bcp.2020.114315_b0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FS Committee investigators, evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcp.2020.114315_b0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/ATVBAHA.118.310955","article-title":"Novel antiplatelet therapies for atherothrombotic diseases","volume":"39","author":"Majithia","year":"2019","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.bcp.2020.114315_b0035","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2019.11.072","article-title":"Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar","volume":"75","author":"Preiss","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.bcp.2020.114315_b0040","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2017.02.012","article-title":"Use of antiplatelet therapy\/DAPT for Post-PCI patients undergoing noncardiac surgery","volume":"69","author":"Banerjee","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.bcp.2020.114315_b0045","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: The STOPDAPT-2 Randomized Clinical Trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"issue":"41","key":"10.1016\/j.bcp.2020.114315_b0050","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","article-title":"Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study","volume":"38","author":"Cuisset","year":"2017","journal-title":"Eur. Heart. J."},{"issue":"16","key":"10.1016\/j.bcp.2020.114315_b0055","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.jacc.2017.02.029","article-title":"Bleeding-related deaths in relation to the duration of dual-antiplatelet therapy after coronary stenting","volume":"69","author":"Palmerini","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.bcp.2020.114315_b0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.bcp.2020.114315_b0065","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7599","key":"10.1016\/j.bcp.2020.114315_b0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature17631","article-title":"NOD1 and NOD2 signalling links ER stress with inflammation","volume":"532","author":"Keestra-Gounder","year":"2016","journal-title":"Nature"},{"issue":"7752","key":"10.1016\/j.bcp.2020.114315_b0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","article-title":"Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2","volume":"568","author":"Zhou","year":"2019","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.bcp.2020.114315_b0080","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.114.013743","article-title":"Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis","volume":"131","author":"Zhang","year":"2015","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bcp.2020.114315_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069619","article-title":"Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway","volume":"8","author":"Rickard","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.bcp.2020.114315_b0090","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1021\/jm401841p","article-title":"Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway","volume":"57","author":"Jakopin","year":"2014","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2020.114315_b0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1160\/TH10-05-0285","article-title":"BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism","volume":"104","author":"Zhang","year":"2010","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.bcp.2020.114315_b0100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/CIRCULATIONAHA.116.026995","article-title":"Platelets express activated P2Y12 receptor in patients with diabetes mellitus","volume":"136","author":"Hu","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2020.114315_b0105","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/ATVBAHA.117.309751","article-title":"Class III PI3K positively regulates platelet activation and thrombosis via PI(3)P-directed function of NADPH oxidase","volume":"37","author":"Liu","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114315_b0110","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1160\/TH11-06-0400","article-title":"BF061, a novel antiplatelet and antithrombotic agent targeting P2Y receptor and phosphodiesterase","volume":"106","author":"Hu","year":"2011","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.bcp.2020.114315_b0115","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1538-7836.2012.04894.x","article-title":"Increased platelet activation and thrombosis in transgenic mice expressing constitutively active P2Y12","volume":"10","author":"Zhang","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bcp.2020.114315_b0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0036-1571307","article-title":"Platelet function tests in bleeding disorders","volume":"42","author":"Lassila","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.bcp.2020.114315_b0125","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1055\/s-0039-1688791","article-title":"Standardization of Light Transmission Aggregometry for Diagnosis of Platelet Disorders: An Inter-Laboratory External Quality Assessment","volume":"119","author":"Althaus","year":"2019","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.bcp.2020.114315_b0130","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/jth.14240","article-title":"Small molecule targeting the Rac1-NOX2 interaction prevents collagen-related peptide and thrombin-induced reactive oxygen species generation and platelet activation","volume":"16","author":"Akbar","year":"2018","journal-title":"J Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.bcp.2020.114315_b0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2008.03.021","article-title":"Spatially distinct production of reactive oxygen species regulates platelet activation","volume":"45","author":"Bakdash","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.bcp.2020.114315_b0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1476-5381.2012.02130.x","article-title":"The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner","volume":"168","author":"Vara","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114315_b0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bcp.2019.02.016","article-title":"Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin","volume":"163","author":"Cammisotto","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114315_b0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.redox.2017.08.021","article-title":"Regulation of platelet activation and thrombus formation by reactive oxygen species","volume":"14","author":"Qiao","year":"2018","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114315_b0155","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","article-title":"Oxidative stress inflammation, and vascular aging in hypertension","volume":"70","author":"Guzik","year":"2017","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.bcp.2020.114315_b0160","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/ATVBAHA.110.207522","article-title":"Signaling during platelet adhesion and activation","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"10.1016\/j.bcp.2020.114315_b0165","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2017-03-773614","article-title":"Integrin alphaIIbbeta3 outside-in signaling","volume":"130","author":"Durrant","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcp.2020.114315_b0170","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1538-7836.2005.01429.x","article-title":"GPVI and integrin alphaIIb beta3 signaling in platelets","volume":"3","author":"Watson","year":"2005","journal-title":"J. Thromb Haemost."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2020.114315_b0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jth.12235","article-title":"Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb-IX-V, and CLEC-2","volume":"11","author":"Ozaki","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.bcp.2020.114315_b0180","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood-2009-02-205328","article-title":"The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo","volume":"114","author":"Gratacap","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2020.114315_b0185","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","article-title":"Cellular functions regulated by Src family kinases","volume":"13","author":"Thomas","year":"1997","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"issue":"50","key":"10.1016\/j.bcp.2020.114315_b0190","doi-asserted-by":"crossref","first-page":"52293","DOI":"10.1074\/jbc.M406342200","article-title":"Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites","volume":"279","author":"Lecut","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114315_b0195","doi-asserted-by":"crossref","unstructured":"P.A. Smethurst, L. Joutsi-Korhonen, M.N. O'Connor, E. Wilson, N.S. Jennings, S.F. Garner, Y. Zhang, C.G. Knight, T.R. Dafforn, A. Buckle, I.J. MJ, P.G. De Groot, N.A. Watkins, R.W. Farndale, W.H. Ouwehand, Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody, Blood 103(3) (2004) 903-11.","DOI":"10.1182\/blood-2003-01-0308"},{"issue":"4","key":"10.1016\/j.bcp.2020.114315_b0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1538-7836.2005.01764.x","article-title":"Gain- and loss-of-function mutants confirm the importance of apical residues to the primary interaction of human glycoprotein VI with collagen","volume":"4","author":"O'Connor","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bcp.2020.114315_b0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.thromres.2008.12.006","article-title":"Nitrite or sildenafil, but not BAY 41\u20132272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress","volume":"124","author":"Dias-Junior","year":"2009","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.bcp.2020.114315_b0210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.thromres.2013.09.014","article-title":"The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption","volume":"132","author":"Sousa-Santos","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcp.2020.114315_b0215","doi-asserted-by":"crossref","first-page":"1860513","DOI":"10.1155\/2018\/1860513","article-title":"Pulmonary Arterial Hypertension And Endothelial Dysfunction Is Linked to NADPH oxidase-derived superoxide formation in venous thrombosis and pulmonary embolism in mice","volume":"2018","author":"Brandt","year":"2018","journal-title":"Oxid. Med. Cell Longev"},{"issue":"3","key":"10.1016\/j.bcp.2020.114315_b0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","article-title":"Current and future antiplatelet therapies: emphasis on preserving haemostasis","volume":"15","author":"McFadyen","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"10073","key":"10.1016\/j.bcp.2020.114315_b0225","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bcp.2020.114315_b0230","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bcp.2020.114315_b0235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/eurheartj\/ehz593","article-title":"Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry","volume":"41","author":"Simonsson","year":"2020","journal-title":"Eur. Heart. J."},{"issue":"13","key":"10.1016\/j.bcp.2020.114315_b0240","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2015-04-641654","article-title":"Fibrin activates GPVI in human and mouse platelets","volume":"126","author":"Alshehri","year":"2015","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.bcp.2020.114315_b0245","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/bloodadvances.2017007732","article-title":"Fibrin and D-dimer bind to monomeric GPVI","volume":"1","author":"Onselaer","year":"2017","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.bcp.2020.114315_b0250","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jth.13919","article-title":"Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation","volume":"16","author":"Induruwa","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bcp.2020.114315_b0255","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.2515","article-title":"Arterial thrombosis\u2013insidious, unpredictable and deadly","volume":"17","author":"Jackson","year":"2011","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.bcp.2020.114315_b0260","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.drudis.2014.06.005","article-title":"New advances in treating thrombotic diseases: GPVI as a platelet drug target","volume":"19","author":"Jiang","year":"2014","journal-title":"Drug Discov Today"},{"issue":"11","key":"10.1016\/j.bcp.2020.114315_b0265","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1055\/s-0039-1695770","article-title":"From patients to platelets and back again: pharmacological approaches to glycoprotein vi, a thrilling antithrombotic target with minor bleeding risks","volume":"119","author":"Martins Lima","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcp.2020.114315_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100592","article-title":"Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI","volume":"38","author":"Nurden","year":"2019","journal-title":"Blood Rev."},{"issue":"17","key":"10.1016\/j.bcp.2020.114315_b0275","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.110.980623","article-title":"Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans","volume":"123","author":"Ungerer","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bcp.2020.114315_b0280","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/ATVBAHA.118.312314","article-title":"Safety and tolerability, pharmacokinetics, and pharmacodynamics of ACT017, an antiplatelet GPVI (Glycoprotein VI) Fab","volume":"39","author":"Voors-Pette","year":"2019","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114315_b0285","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1538-7836.2012.04734.x","article-title":"ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways","volume":"10","author":"Arthur","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcp.2020.114315_b0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.redox.2013.12.023","article-title":"The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation","volume":"2","author":"Walsh","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2020.114315_b0295","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2015.07.154","article-title":"NOD2 activation induces oxidative stress contributing to mitochondrial dysfunction and insulin resistance in skeletal muscle cells","volume":"89","author":"Maurya","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2020.114315_b0300","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.bcp.2020.114315_b0305","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.119.045256","article-title":"From CANTOS to CIRT to COLCOT to clinic: will all atherosclerosis patients soon be treated with combination lipid-lowering and inflammation-inhibiting agents?","volume":"141","author":"Ridker","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2020.114315_b0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI122955","article-title":"Functional significance of the platelet immune receptors GPVI and CLEC-2","volume":"129","author":"Rayes","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bcp.2020.114315_b0315","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.7150\/thno.28892","article-title":"Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix","volume":"9","author":"Beziere","year":"2019","journal-title":"Theranostics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:21:35Z","timestamp":1757769695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220305517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":63,"alternative-id":["S0006295220305517"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114315","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114315"}}